$76.52
3.685.05%
At close: -
$76.15
-0.37-0.48%
After Hours: Dec 20, 6:06 PM EDT
Comments
Loading...
Praxis Precision Medicine (NASDAQ:PRAX) Stock, Earnings Estimates, EPS, And Revenue
Praxis Precision Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 4
EPS Estimate
$-2.040
Quarterly Revenue Estimate
$380K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$1.6M
Analyze the earnings history of Praxis Precision Medicine using advanced sorting and filters.
Data brought to you by Benzinga APIs
Praxis Precision Medicine (PRAX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $-2.75 | $-1.99 | -38.2 % |
| Jun 2024 | 2024-08-13 | $-1.74 | $-2.31 | 24.7 % |
| Mar 2024 | 2024-05-13 | $-2.84 | $-2.08 | -36.5 % |
| Dec 2023 | 2024-03-05 | $-2.97 | $-3.13 | 5.11 % |
Praxis Precision Medicine (PRAX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $302.00K | $300.00K | 0.67 % |
| Jun 2024 | 2024-08-13 | $357.00K | $830.00K | -57.0 % |
| Mar 2024 | 2024-05-13 | $431.00K | $1.62M | -73.4 % |
| Dec 2023 | 2024-03-05 | $515.00K | $50.00K | 930.0 % |
FAQ
When is Praxis Precision Medicine (NASDAQ:PRAX) reporting earnings?
Praxis Precision Medicine (PRAX) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Praxis Precision Medicine (NASDAQ:PRAX)?
The Actual EPS was $-2.75, which missed the estimate of $-1.99.
What were Praxis Precision Medicine’s (NASDAQ:PRAX) revenues?
The Actual Revenue was $302K, which beat the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.